Automating cell manufacturing: customized solutions for research, development and industry
Sponsor
Cell therapy holds promise in improving outcomes for many difficult-to-treat diseases. However, this therapeutic strategy also comes with challenges that limit rollouts on a more impactful scale. Cell material is difficult to handle and maintain. Establishing a scalable and reliable manufacturing workflow is complex and very expensive, making the cost of developing and delivering cell therapies prohibitive. Furthermore, quality control processes for cell-based therapeutics pose unique issues compared to traditional pharmaceutical manufacturing. This webinar demonstrates how a streamlined solution that combines equipment, software and training can help tackle many of these challenges. Find out how to make cell manufacturing simpler and safer by automating custom processes on a closed platform, building bias-free quality control, and planning protocol-aligned training for your staff. The upshot is an easier transition from research to manufacturing.
- Learn about the advantages of an integrated setup for automated cell manufacturing, in-process control and quality control
- Find out how customization services accommodate unique process requirements
- Understand aspects of process automation that facilitate the transition from research workflows to large-scale manufacturing
- See how protocol-aligned training programs promote quality and safety within cell manufacturing and quality control teams
- Discover strategies to overcome challenges in cell manufacturing and quality control based on a bespoke solution for your specific application.
SPEAKERS
You might also like
Closed system solutions for cell and gene therapy manufacturing
Navigating CAR-T manufacturing: from research to GMP readiness
iPSC cell line development and manufacture for cell therapies
Revolutionizing cell and gene therapy with digitalization: a panel discussion with industry leaders
